Natco Pharma Shares Rally 9% Despite Weak Q2 Results; Details Inside

Revenue from operations or top line declined 29% YoY to Rs 967 crore in Q2FY27, from Rs 1,363 crore in the year-ago period.

Advertisement
Read Time: 3 mins
Natco Pharma Shares Rally
Source: NDTV Profit
Quick Read
Summary is AI-generated, newsroom-reviewed
  • Natco Pharma shares surged up to 8.64% to Rs 882.45 intraday on Monday
  • Shares traded 6.41% higher at Rs 864.30 as BSE Sensex rose 0.5% to 82,011
  • Q2FY27 net profit fell 60.8% to Rs 203 crore from Rs 518 crore year-on-year
Did our AI summary help?
Let us know.

Pharmaceutical major Natco Pharma shares rallied on Monday, with the scrip zooming up to 8.64% to hit an intraday high of Rs 882.45 per share. 

At 9:21 am, Natco Pharma shares were trading 6.41% higher at Rs 864.30. In comparison, BSE Sensex was trading 0.5% higher at 82,011 level. 

Advertisement

The sharp uptick came despite weak September quarter results.

Natco Pharma Ltd. reported a 60.8% year-on-year (YoY) decline in net profit to Rs 203 crore in the September quarter of financial year 2027 (Q2FY27), compared with Rs 518 crore in the corresponding quarter last year (Q2FY26).

Revenue from operations or top line declined 29% YoY to Rs 967 crore in Q2FY27, from Rs 1,363 crore in the year-ago period.

Advertisement

At the operating level, earnings before interest, taxes, depreciation and amortisation (EBITDA) fell 55.4% to Rs 258.3 crore, compared with Rs 579 crore a year ago.

READ | Natco Pharma Q2 Results: Net Profit Falls 61% To Rs 203 Crore, Revenue Declines 29%; Stock Tumbles 3%

Advertisement

Subsequently, the pharma major's EBITDA margin squeezed 1,580 basis points (bps) to 26.7% in the quarter under review from 42.5% in the corresponding quarter last year, marking a decline of 1,580 basis points.

Other income also declined to Rs 52 crore from Rs 100 crore in the year-ago period.

Natco Pharma also declared a second interim dividend of Rs 1.25 for the FY27. The company has fixed November 19 as Record Date for the dividend.

In an exchange filing, Natco Pharma said, "The Board of Directors of the Company at their meeting held today have Declared 2nd interim dividend of Rs 1.25 per share each per equity share of Rs  each for the financial year 2026-27. The date for taking on record of its shareholders eligible for the purpose of payment of 2nd interim dividend i.e., record date is fixed as Thursday, November 19, 2026."

The payment of the interim dividend will start from November 27, 2026, Natco Pharma said. 

Natco Pharma Share Price History 

Natco Pharma shares have gained 3.87% over the past week and 6.25% in two weeks. The stock has risen 6.35% over the past month, with an absolute gain of Rs 49.90.

Advertisement

However, it remains under pressure over longer periods, falling 6.71% in three months and 29.71% in six months. The stock is down 5.26% so far in 2026 and has declined 38.80% over two years.

On a longer-term basis, Natco Pharma shares have gained 3.29% in one year, 8.88% in three years and 32.69% over five years. Over the past decade, the stock has delivered a gain of 32.69%.

READ | Stock Market Today: Sensex Zooms 550 Points, Nifty 50 Near 25,300; Belrise Industries Rallies 11%, Kaynes Tanks 15%

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.


Loading...